Aspen Neuroscience
Developer of autologous cell therapies and personalized medicines designed for a broad spectrum of diseases, starting with Parkinson's disease. The company's platform reprograms a patient's own cells ...
Valuation
$346M
Market implied
Share Price
N/A
Total Raised
$379M
Last Round
N/A